Upregulation of HSP27 in a transgenic model of ALS

89Citations
Citations of this article
55Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Mutations of the SOD1 gene underlie 1 form of familial amyotrophic lateral sclerosis (ALS). Their pathogenic mechanism remains uncertain, but is thought to involve oxidative stress and abnormal protein aggregation, 2 processes known to induce heat shock proteins (HSPs). We studied the expression of 3 HSPs (αB-crystallin, HSP27, and HSP70) in transgenic mice overexpressing human mutant (G93A and G37R) SOD1 using a combination of immunohistochemistry and immunoblotting. Quantitative Western blot analysis demonstrated αB-crystallin and HSP27 to be upregulated in the spinal cord of mutant SOD1 mice compared to mice overexpressing wild-type SOD1. HSP70 levels were normal. Immunocytochemical studies of the ventral horn of the spinal cord demonstrated HSP27 to be localized in the nucleus of neurons and glial cells in presymptomatic and early symptomatic animals, where it often was punctate in pattern. In the later stages of the disease, HSP27 was predominantly present in the cytoplasm of reactive glial cells. The early nuclear localization was confirmed by Western blot analysis of spinal cord nuclear and cytoplasmic fractions. In contrast to HSP27, αB-crystallin was localized exclusively in the cytoplasm of reactive glial cells.

Cite

CITATION STYLE

APA

Vleminckx, V., Van Damme, P., Goffin, K., Delye, H., Van Den Bosch, L., & Robberecht, W. (2002). Upregulation of HSP27 in a transgenic model of ALS. Journal of Neuropathology and Experimental Neurology, 61(11), 968–974. https://doi.org/10.1093/jnen/61.11.968

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free